Werewolf Therapeutics Inc

NASDAQ:HOWL   3:57:27 PM EDT
14.97
-0.01 (-0.07%)
Earnings Announcements

Werewolf Therapeutics Reports Third Quarter 2021 Financial Results And Business Update

Published: 11/10/2021 12:29 GMT
Werewolf Therapeutics Inc (HOWL) - Werewolf Therapeutics Reports Third Quarter 2021 Financial Results and Business Update.
On Track to File Two Inds in First Half of 2022.
Qtrly Loss per Share $0.51.
Q3 Earnings per Share View $-0.45 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.52

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.52

More details on our Analysts Page.